Literature DB >> 19570751

Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy.

Brunangelo Falini, Maria Paola Martelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570751      PMCID: PMC2704299          DOI: 10.3324/haematol.2009.008250

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  29 in total

Review 1.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Authors:  H Stein; H D Foss; H Dürkop; T Marafioti; G Delsol; K Pulford; S Pileri; B Falini
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma.

Authors:  Arcangelo Liso; Enrico Tiacci; Roberto Binazzi; Karen Pulford; Roberta Benedetti; Alessandra Carotti; Franco Aversa; Brunangelo Falini
Journal:  Lancet Oncol       Date:  2004-02       Impact factor: 41.316

3.  Model of inhibition of the NPM-ALK kinase activity by herbimycin A.

Authors:  Francesco Turturro; Marilyn D Arnold; Audrey Y Frist; Karen Pulford
Journal:  Clin Cancer Res       Date:  2002-01       Impact factor: 12.531

4.  Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.

Authors:  B Falini; K Pulford; A Pucciarini; A Carbone; C De Wolf-Peeters; J Cordell; M Fizzotti; A Santucci; P G Pelicci; S Pileri; E Campo; G Ott; G Delsol; D Y Mason
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

Review 5.  Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.

Authors:  Brunangelo Falini; David Y Mason
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

6.  High-dose therapy and autologous stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive ALK-negative anaplastic large-cell lymphoma.

Authors:  K W Zamkoff; M D Matulis; A C Mehta; M W Beaty; R E Hutchison; T C Gentile
Journal:  Bone Marrow Transplant       Date:  2004-03       Impact factor: 5.483

7.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

8.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

9.  Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein.

Authors:  Paolo Bonvini; Henry Dalla Rosa; Nadia Vignes; Angelo Rosolen
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  17 in total

Review 1.  Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity.

Authors:  Philip A Thompson; Stephen Lade; Howard Webster; Gail Ryan; H Miles Prince
Journal:  Haematologica       Date:  2010-08-26       Impact factor: 9.941

2.  Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.

Authors:  Melissa G Lechner; Stephen Lade; Daniel J Liebertz; H Miles Prince; Garry S Brody; Howard R Webster; Alan L Epstein
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

Review 3.  Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysis.

Authors:  Philip A Thompson; H Miles Prince
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

4.  Deciphering the folding transition state structure and denatured state properties of nucleophosmin C-terminal domain.

Authors:  Flavio Scaloni; Luca Federici; Maurizio Brunori; Stefano Gianni
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

5.  A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.

Authors:  F Abate; M Todaro; J-A van der Krogt; M Boi; I Landra; R Machiorlatti; F Tabbò; K Messana; C Abele; A Barreca; D Novero; M Gaudiano; S Aliberti; F Di Giacomo; T Tousseyn; E Lasorsa; R Crescenzo; L Bessone; E Ficarra; A Acquaviva; A Rinaldi; M Ponzoni; D L Longo; S Aime; M Cheng; B Ruggeri; P P Piccaluga; S Pileri; E Tiacci; B Falini; B Pera-Gresely; L Cerchietti; J Iqbal; W C Chan; L D Shultz; I Kwee; R Piva; I Wlodarska; R Rabadan; F Bertoni; G Inghirami
Journal:  Leukemia       Date:  2014-12-23       Impact factor: 11.528

6.  Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.

Authors:  Jing Chen; Yong Zhang; Michael N Petrus; Wenming Xiao; Alina Nicolae; Mark Raffeld; Stefania Pittaluga; Richard N Bamford; Masao Nakagawa; Sunny Tianyi Ouyang; Alan L Epstein; Marshall E Kadin; Annarose Del Mistro; Richard Woessner; Elaine S Jaffe; Thomas A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-29       Impact factor: 11.205

7.  Primary anaplastic large cell lymphomas of the pancreas.

Authors:  Ling Chen; John R Krause; Haiying Zhang
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-06-07

8.  A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma.

Authors:  Hongbo Wang; Wei Wei; Jing-Ping Zhang; Zhihui Song; Yangyang Li; Wenming Xiao; Yijun Liu; Mu-Sheng Zeng; Michael N Petrus; Craig J Thomas; Marshall E Kadin; Masao Nakagawa; Thomas A Waldmann; Yibin Yang
Journal:  Leukemia       Date:  2020-11-12       Impact factor: 12.883

9.  Change in the diagnosis from classical Hodgkin's lymphoma to anaplastic large cell lymphoma by (18)F flourodeoxyglucose positron emission tomography/computed tomography: Importance of recognising disease pattern on imaging and immunohistochemistry.

Authors:  Raja Senthil; Ranjan Kumar Mohapatra; Mouleeswaran Koramadai Sampath; Sumati Sundaraiya
Journal:  Indian J Nucl Med       Date:  2016 Jan-Mar

10.  Pitfalls in the diagnosis of anaplastic large cell lymphoma with a small cell pattern.

Authors:  Rowan L Grigoropoulos; Penny Wright; Mars B van T'veer; Mike A Scott; George A Follows
Journal:  Case Rep Hematol       Date:  2013-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.